Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 4Rituximab 3ibrutinib 2Peripheral Blood Stem Cell Transplantation 2venetoclax 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1ibritumomab tiuxetan 1fludarabine phosphate 1fludarabine 1brexucabtagene autoleucel 1acalabrutinib 1Vincristine 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Ribavirin 1Precision Medicine 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Pemetrexed 1NVP-BKM120 1Methotrexate 1Loratadine 1Immunohistochemistry 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Mantle-Cell × Sugars × Clear all
NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
1 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡